Trial
NCT04401410
Anti-SARS Cov-2 T Cell Infusions for COVID 19
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
Center for Cell and Gene Therapy, Baylor College of Medicine; AlloVir; The Methodist Hospital Research Institute
Condition
SARS-CoV 2
Intervention
Dose Finding Phase (MTD)
Why stopped
Due to trial's eligibility criteria and the low census of hospitalized COVID-19 patients meeting eligibility criteria, the Sponsor will be unable to enroll a meaningful number of patients in this single-center trial in a reasonable time frame.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-19